This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: FB CBI COH EXC PMCS


Advent Software (ADVS) downgraded at Wedbush to Neutral from Outperform, Wedbush said. $30 price target. Bookings could slow, along with the rest of the market.

Advanced Energy Industries (AEIS) upgraded to buy at TheStreet Ratings.

Alkermes PLC (ALKS) upgraded to buy at TheStreet Ratings.

Chicago Bridge & Iron (CBI - Get Report) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $39 price target. Shaw deal adds risk to the investment thesis.

Chicago Bridge & Iron downgraded at Lazard from Buy to Neutral, Lazard said. Shaw purchase is a divergence from the company's de-risking strategy.

Coach (COH - Get Report) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $67 price target. Company will spend a few quarters investing in future growth.

Exelon (EXC - Get Report) rated new Equal-weight at Morgan Stanley. Valuation call, based on a $40 price target.

Facebook (FB - Get Report) upgraded at Bernstein from Underperform to Market Perform, Bernstein said. Valuation call, based on a $23 price target.

Hudson City Bancorp (HCBK) upgraded at Guggenheim to Buy from Neutral, Guggenheim said. $7 price target. Earnings should bottom in the third quarter.

PMC Sierra (PMCS) downgraded at Wunderlich to Hold, Wunderlich said. $6.50 price target. CFO left and the company has pushed out its timeline for a potential recovery.

Shaw Group (SHAW) downgraded at UBS to Neutral from Buy, UBS said. $44 price target. Stock generally prices in acquisition.

Unisource Energy (UNS) downgraded at DA Davidson from Buy to Neutral, DA Davidson said. Valuation call, following a 14% run in the stock.

Vertex Pharmaceuticals (VRTX) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $57 price target. Company is realizing lower Incivek sales.

Watsco (WSO) rated new Neutral at Lazard. Valuation call.


Anadarko Petroleum (APC) estimates raised at UBS through 2013, UBS said. Strong 2Q and guidance raise. Buy rating and $105 price target.

Cirrus Logic (CRUS) numbers increased at Sterne Agee through 2014, Sterne Agee said. Company is seeing a steep ramp in business. Buy rating and new $48 price target.

Cablevision Systems (CVC) removed from Top Picks Live! at Citigroup. Valuation call. Buy rating and $21 price target.

Group 1 Automotive (GPI) numbers raised at Morgan Stanley. Shares of GPI now seen reaching $46, according to Morgan Stanley. Estimates also increased, as the company is realizing higher margins.

Humana (HUM) estimates, target reduced at Credit Suisse. HUM estimates were cut through 2013, Credit Suisse said. Company lowered its guidance. Outperform rating and new $94 price

Seagate (STX) estimates, target cut at BofA/Merrill. Shares of STX now seen reaching $31, according to Bank of America/Merrill Lynch. Estimates also reduced, given the company's new guidance. Neutral rating.

Vertex Pharmaceuticals (VRTX) numbers lowered at UBS. Shares of VRTX now seen reaching $60, UBS said. Estimates also lowered as Incivek guidance taken down. Buy rating.

Weight Watchers (WTW) numbers cut at Credit Suisse. Shares of WTW now seen reaching $82, according to Credit Suisse. Estimates also reduced, given lower expected sales. Outperform rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CBI $38.66 -2.10%
COH $40.67 -1.60%
EXC $34.58 -1.50%
FB $117.74 -0.70%
PMCS $11.65 0.52%


Chart of I:DJI
DOW 17,719.05 -172.11 -0.96%
S&P 500 2,057.92 -23.51 -1.13%
NASDAQ 4,756.0180 -61.5760 -1.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs